Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hormonal Regulation01:33

Hormonal Regulation

30.4K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
30.4K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

2.9K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

2.7K
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.7K
Hormonal Regulation of Blood Pressure01:17

Hormonal Regulation of Blood Pressure

7.8K
Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
7.8K
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

615
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
615
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

1.8K
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Precision Reprogramming-Restoring Function to Aged Cells.

Cellular reprogramming·2025
Same author

Integrating population and single-cell variations in vaccine responses identifies a naturally adjuvanted human immune setpoint.

Immunity·2024
Same author

Telehealth Expansion, Internet Speed, and Primary Care Access Before and During COVID-19.

JAMA network open·2024
Same author

ET-traps: Potential therapeutics for preeclampsia.

Drug discovery today·2023
Same author

Multiscale integration of human and single-cell variations reveals unadjuvanted vaccine high responders are naturally adjuvanted.

medRxiv : the preprint server for health sciences·2023
Same author

Access to American College of Surgeons Committee on Trauma-Verified Trauma Centers in the US, 2013-2019.

JAMA·2022
Same journal

Ovarian reserve markers in World Health Organization type 1 anovulatory disorders: a systematic review and meta-analysis.

Reproductive biomedicine online·2026
Same journal

Effect of embryo culture medium pH on live birth rate after IVF/ICSI: a double-blind, multicentre, randomized trial.

Reproductive biomedicine online·2026
Same journal

Response to: Clarifying Molecular Specificity and Outcome Definitions in Progestogen Route Meta-Analysis.

Reproductive biomedicine online·2026
Same journal

Polyendocrine metabolic ovarian syndrome and cardiometabolic profile in offspring: a propensity score matched cohort study.

Reproductive biomedicine online·2026
Same journal

Antinuclear antibodies in women with recurrent early pregnancy loss: prevalence and impact on subsequent pregnancy outcome.

Reproductive biomedicine online·2026
Same journal

Effect of adenomyosis on the cumulative live birth rate in oocyte donation cycles: a retrospective analysis.

Reproductive biomedicine online·2026
See all related articles

Related Experiment Video

Updated: May 4, 2026

Subcutaneous Angiotensin II Infusion using Osmotic Pumps Induces Aortic Aneurysms in Mice
07:21

Subcutaneous Angiotensin II Infusion using Osmotic Pumps Induces Aortic Aneurysms in Mice

Published on: September 28, 2015

39.9K

Endothelin-1: a key pathological factor in pre-eclampsia?

Arjun Jain1

  • 1Centre for Trophoblast Research, Department of Physiology Development and Neuroscience, University of Cambridge, UK. jain_arjun@yahoo.com

Reproductive Biomedicine Online
|September 22, 2012
PubMed
Summary
This summary is machine-generated.

Endothelin-1 (ET-1) contributes to hypertension and stress pathways in pre-eclampsia. Blocking ET-1 receptors may offer strategies to manage pre-eclampsia pathology by mitigating oxidative and endoplasmic reticulum stress.

More Related Videos

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles
05:31

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles

Published on: January 26, 2024

1.4K
Trophoblast Cell Recovery from Angiogenesis-Tube Formation Assay for Differentiation Marker Expression Analysis
05:30

Trophoblast Cell Recovery from Angiogenesis-Tube Formation Assay for Differentiation Marker Expression Analysis

Published on: November 8, 2024

1.0K

Related Experiment Videos

Last Updated: May 4, 2026

Subcutaneous Angiotensin II Infusion using Osmotic Pumps Induces Aortic Aneurysms in Mice
07:21

Subcutaneous Angiotensin II Infusion using Osmotic Pumps Induces Aortic Aneurysms in Mice

Published on: September 28, 2015

39.9K
Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles
05:31

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles

Published on: January 26, 2024

1.4K
Trophoblast Cell Recovery from Angiogenesis-Tube Formation Assay for Differentiation Marker Expression Analysis
05:30

Trophoblast Cell Recovery from Angiogenesis-Tube Formation Assay for Differentiation Marker Expression Analysis

Published on: November 8, 2024

1.0K

Area of Science:

  • Cardiovascular Research
  • Endocrinology
  • Pathophysiology

Background:

  • Endothelin-1 (ET-1) is a potent vasoactive peptide involved in various signaling pathways.
  • Hypertension is a common feature of pre-eclampsia, prompting research into ET-1's role.
  • ET-1 is increasingly recognized for its involvement in pre-eclampsia pathogenesis.

Purpose of the Study:

  • To investigate the role of Endothelin-1 (ET-1) in the development of hypertension and stress pathways in pre-eclampsia.
  • To explore the potential of ET-1 receptor antagonists in managing pre-eclampsia-associated pathologies.

Main Methods:

  • Review of existing research on ET-1 signaling in pre-eclampsia.
  • Analysis of ET-1's involvement in oxidative stress and endoplasmic reticulum stress.
  • Evaluation of the therapeutic potential of ET-receptor antagonists.

Main Results:

  • ET-1 contributes to hypertension in pre-eclampsia.
  • ET-1 activates signaling molecules that induce oxidative and endoplasmic reticulum stress.
  • ET-receptor antagonists show potential in blocking these stress pathways.

Conclusions:

  • ET-1 plays a significant role in pre-eclampsia pathophysiology, including hypertension and cellular stress.
  • Targeting ET-1 signaling with receptor antagonists may provide a therapeutic strategy for pre-eclampsia.
  • Further research is warranted to develop ET-1-targeted interventions for pre-eclampsia.